$0.55
0.80% today
NYSE, Apr 03, 05:12 pm CET
ISIN
US9286611077
Symbol
VNRX
Sector

VolitionRX Target price 2025 - Analyst rating & recommendation

VolitionRX Classifications & Recommendation:

Buy
100%

VolitionRX Price Target

Target Price $4.06
Price $0.54
Potential
Number of Estimates 2
2 Analysts have issued a price target VolitionRX 2026 . The average VolitionRX target price is $4.06. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 1 analysts: 1 Analysts recommend VolitionRX to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the VolitionRX stock has an average upside potential 2026 of . Most analysts recommend the VolitionRX stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 1.23 9.66
57.69% 685.53%
Net Margin -2,422.03% -79.57%
60.68% 96.71%

1 Analyst has issued a sales forecast VolitionRX 2025 . The average VolitionRX sales estimate is

$9.7m
Unlock
. This is
685.53% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$9.7m 685.53%
Unlock
, the lowest is
$9.7m 685.53%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.2m 57.69%
2025
$9.7m 685.53%
Unlock
2026
$29.3m 202.87%
Unlock
2027
$157m 436.04%
Unlock
2028
$233m 48.36%
Unlock
2029
$314m 34.98%
Unlock

1 Analyst has issued a net profit forecast VolitionRX 2025 . The average VolitionRX net profit estimate is

$-7.7m
Unlock
. This is
74.19% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-7.7m 74.19%
Unlock
, the lowest is
$-7.7m 74.19%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-29.8m 38.00%
2025
$-7.7m 74.19%
Unlock
2026
$8.7m 212.48%
Unlock
2027
$127m 1,366.47%
Unlock
2028
$189m 49.25%
Unlock
2029
$252m 32.99%
Unlock

Net Margin

2024 -2,422.03% 60.68%
2025
-79.57% 96.71%
Unlock
2026
29.56% 137.15%
Unlock
2027
80.87% 173.58%
Unlock
2028
81.35% 0.59%
Unlock
2029
80.15% 1.48%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.31 -0.08
38.00% 74.19%
P/E negative
EV/Sales 5.54

1 Analysts have issued a VolitionRX forecast for earnings per share. The average VolitionRX EPS is

$-0.08
Unlock
. This is
74.19% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.08 74.19%
Unlock
, the lowest is
$-0.08 74.19%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.31 38.00%
2025
$-0.08 74.19%
Unlock
2026
$0.09 212.50%
Unlock
2027
$1.32 1,366.67%
Unlock
2028
$1.97 49.24%
Unlock
2029
$2.62 32.99%
Unlock

P/E ratio

Current -1.73 14.57%
2025
-6.76 290.75%
Unlock
2026
6.01 188.91%
Unlock
2027
0.41 93.18%
Unlock
2028
0.27 34.15%
Unlock
2029
0.21 22.22%
Unlock

Based on analysts' sales estimates for 2025, the VolitionRX stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 43.54 26.73%
2025
5.54 87.27%
Unlock
2026
1.83 66.98%
Unlock
2027
0.34 81.35%
Unlock
2028
0.23 32.60%
Unlock
2029
0.17 25.90%
Unlock

P/S ratio

Current 42.44 46.72%
2025
5.40 87.27%
Unlock
2026
1.78 66.98%
Unlock
2027
0.33 81.34%
Unlock
2028
0.22 32.60%
Unlock
2029
0.17 25.90%
Unlock

Current VolitionRX Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
D. Boral Capital
Locked
Locked
Locked Apr 01 2025
D. Boral Capital
Locked
Locked
Locked Mar 31 2025
D. Boral Capital
Locked
Locked
Locked Mar 20 2025
D. Boral Capital
Locked
Locked
Locked Mar 13 2025
D. Boral Capital
Locked
Locked
Locked Mar 12 2025
D. Boral Capital
Locked
Locked
Locked Mar 04 2025
D. Boral Capital
Locked
Locked
Locked Feb 06 2025
Analyst Rating Date
Locked
D. Boral Capital:
Locked
Locked
Apr 01 2025
Locked
D. Boral Capital:
Locked
Locked
Mar 31 2025
Locked
D. Boral Capital:
Locked
Locked
Mar 20 2025
Locked
D. Boral Capital:
Locked
Locked
Mar 13 2025
Locked
D. Boral Capital:
Locked
Locked
Mar 12 2025
Locked
D. Boral Capital:
Locked
Locked
Mar 04 2025
Locked
D. Boral Capital:
Locked
Locked
Feb 06 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today